Oncotarget cover image

Press Release: Genomic Alterations Predictive of Poor Clinical Outcomes in Pan-cancer

Oncotarget

00:00

Genomic Alterations Predictive of Poor Clinical Outcomes in Pan-cancer

Exploring the prognostic significance of TP53 mutations, Mute 31 genes, CDK N2A and PTEN deletions, and MYC amplifications in pan-cancer, indicating their independent prediction of poor survival. Results emphasize the importance of tailored treatment strategies for patients with these genomic alterations.

Transcript
Play full episode

The AI-powered Podcast Player

Save insights by tapping your headphones, chat with episodes, discover the best highlights - and more!
App store bannerPlay store banner
Get the app